February 21, 2012
Aeon Astron Europe B.V. (AAE) successfully held symposium entitled “A Replacement for MMC? - ologen® Collagen Matrix for Tissue Repair” in World Ophthalmology Congress (WOC) 2012 at Abu Dhabi, United Arab Emirates in Feb-19-2012 (Sunday), 09:00~10:15 am. ologen® Collagen Matrix was showcased as an potential alternative to Mitomycin C (MMC), and more than 100 people attended the symposium.
Dr. Robert Ritch from Glaucoma Associates of New York addressed at the opening of the symposium to highlight the significance and benefits of ologen® Collagen Matrix over MMC. Prof. Salvatore Cillino featured updates on ologen® Collagen Matrix as comparable but safer alternative to MMC in a two year randomized study. The symposium came to climax with Dr. Steven Sarkisian’s showcase highlighting techniques that enables successful ophthalmologic surgeries. Prof. Zaher Sbeity further showcased use of ologen® Collagen Matrix in revision surgery and Dr. P. Sathyan & Prof. B. Sridhar Rao featured practical experiences & opportunities of ologen® Collagen Matrix in saving long term medical costs in developing countries. With ologen® Collagen Matrix becoming an increasingly essential alternative to MMC, the symposium gave participants an insights into the critical issues affecting the medical professionals, patients, as well as opportunities and challenges in facing newer and safer alternative to benefit patients without MMC.
February 2012
Aeon Astron Europe B.V. has been awarded a governmental grant up to EURO 500,000 from AgentschapNL for its Biolens projects. This is an international collaboration project among Aeon Astron Europe, Leiden University Medical Center (LUMC), the Netherlands and Industrial Technology Research Institute (ITRI) of Taiwan, R.O.C. The grant will be used to begin development of a multipurpose collagen-based ophthalmic lens for use in refractive correction, corneal repair, and drug delivery. The “International Innovation” subsidy program is an initiative of Agentschap NL, an agency of the Dutch Ministry of Economic Affairs, to encourage the development of bold and unconventional innovations.
September, 2011
Aeon Astron will exhibit at the XXIX Congress of the ESCRS (European Society of Refractive & Cataract Surgeons). Join us at Booth B117 at the Reed Messe from Sep 17-21.
July, 2011
ologen® Symposium held at the World Glaucoma Congress. July 1st, Room 341, Palais des Congrès, Paris.
Scientific Program: Can MMC be replaced? ologen® Collagen Matrix for Eye Tissue Repair
Dr. Julio Lin. VP, Aeon Astron Europe
To Kill or To Guide? Introduction to ologen® Collagen Matrix
Prof. Salvatore Cillino. Department of Experimental Biomedicine and Clinical Neuroscience
Ophthalmology Section Head, University of Palermo
Biodegradable collagen matrix implant vs. mitomycin-C as an adjuvant in trabeculectomy:
a 24-month, randomized clinical trial
Prof. Jimmy Lai. Eye Insitute, The University of Hong Kong
Trabeculectomy with ologen and MMC
Prof. P Sathyan. Chief Glaucoma Services, Aravind Eye Care System
Topic: ologen in Trab - The Indian Experience & Practical Tips For Success
Moderated by Mr. Michael Lai. CEO, Aeon Astron Europe
January 2011
Aeon Astron Europe B.V. is the Glaucoma Industry member of WGA.
